Insights

Innovative Tissue Platform Fluicell's Nexocyte platform enables the development of transplantable tissues aimed at curing serious diseases such as type 1 diabetes, creating opportunities to collaborate with biotech, regenerative medicine, and pharmaceutical companies seeking cutting-edge tissue solutions.

Recent Tech Deployments The launch of Fluicell’s high-precision 3D bioprinter, Biopixlar AER, demonstrates their capability in producing detailed biological tissues, presenting potential sales avenues in bioprinting and tissue engineering markets.

Funding and Growth Recent financial support, including SEK 2.7 million in retroactive research deductions and a $261K investment, indicates ongoing growth and development potential, making the company a promising partner for investors and collaborators in biotech R&D projects.

Market Focus With ambitions to develop tissues for regenerative medicine and drug screening, Fluicell offers opportunities for partnerships with pharmaceutical firms, research institutions, and medical device companies interested in advanced testing and therapeutic solutions.

Technology Integration The company's utilization of advanced bioprinting technology and continuous product launches signal a strong innovation pipeline, ideal for engaging businesses looking for high-precision manufacturing and tissue engineering capabilities.

Fluicell Tech Stack

Fluicell uses 8 technology products and services including C3.js, jsDelivr, Cookiebot, and more. Explore Fluicell's tech stack below.

  • C3.js
    Charting
  • jsDelivr
    Content Delivery Network
  • Cookiebot
    Cookie Compliance
  • Cookie Notice
    Cookie Compliance
  • Moment.js
    Javascript Libraries
  • Cloudflare Bot Management
    Security
  • AddToAny Share Buttons
    Web Platform Extensions
  • Apache HTTP Server
    Web Servers

Fluicell's Email Address Formats

Fluicell uses at least 1 format(s):
Fluicell Email FormatsExamplePercentage
First@fluicell.comJohn@fluicell.com
70%
First.Last@fluicell.comJohn.Doe@fluicell.com
26%
Last@fluicell.comDoe@fluicell.com
4%

Frequently Asked Questions

Where is Fluicell's headquarters located?

Minus sign iconPlus sign icon
Fluicell's main headquarters is located at 8c Flöjelbergsgatan Mölndal, Västra Götaland 431 37 Sweden. The company has employees across 1 continents, including Europe.

What is Fluicell's phone number?

Minus sign iconPlus sign icon
You can contact Fluicell's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Fluicell's stock symbol?

Minus sign iconPlus sign icon
Fluicell is a publicly traded company; the company's stock symbol is FLUI.ST.

What is Fluicell's official website and social media links?

Minus sign iconPlus sign icon
Fluicell's official website is fluicell.com and has social profiles on LinkedIn.

What is Fluicell's SIC code NAICS code?

Minus sign iconPlus sign icon
Fluicell's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Fluicell have currently?

Minus sign iconPlus sign icon
As of June 2026, Fluicell has approximately 16 employees across 1 continents, including Europe. Key team members include Ceo: C. T.Chief Technology Officer: G. D. M. J.Chief Marketing And Communications Officer: J. H.. Explore Fluicell's employee directory with LeadIQ.

What industry does Fluicell belong to?

Minus sign iconPlus sign icon
Fluicell operates in the Biotechnology Research industry.

What technology does Fluicell use?

Minus sign iconPlus sign icon
Fluicell's tech stack includes C3.jsjsDelivrCookiebotCookie NoticeMoment.jsCloudflare Bot ManagementAddToAny Share ButtonsApache HTTP Server.

What is Fluicell's email format?

Minus sign iconPlus sign icon
Fluicell's email format typically follows the pattern of First@fluicell.com. Find more Fluicell email formats with LeadIQ.

When was Fluicell founded?

Minus sign iconPlus sign icon
Fluicell was founded in 2012.

Fluicell

Biotechnology ResearchVästra Götaland, Sweden11-50 Employees

Fluicell is transforming how we treat disease with one-of-a-kind tissue solutions for regenerative medicine and drug screening. With the groundbreaking Nexocyte platform, based on twenty years of disruptive and patent-protected R&D, we are creating new ways to target serious diseases using precision-engineered biological tissues. Our transplantable tissues have the potential to help patients living with uncurable tissue damage related to cardiac, pulmonary, metabolic, kidney and other diseases. Fluicell’s first ambitious goal is to develop transplantable tissues to cure type 1 diabetes, impacting the lives of millions of patients. Nexocyte-generated tissues also enable our world-leading partners to advance their drug-screening capabilities for the development of game-changing medicines.

Section iconCompany Overview

Headquarters
8c Flöjelbergsgatan Mölndal, Västra Götaland 431 37 Sweden
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
FLUI.ST
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2012
Employees
11-50

Section iconFunding & Financials

  • $1M

    Fluicell's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Fluicell's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.